AxoGen(AXGN) - 2025 Q3 - Earnings Call Transcript

AxoGen (NasdaqCM:AXGN) Q3 2025 Earnings Call October 29, 2025 08:00 AM ET Company ParticipantsMichael Dale - CEO and DirectorLindsey Hartley - CFOCaitlin Roberts - Director of MedTech Equity ResearchJens Kemp - CMORick Ditto - VP of Global Health Economics, Reimbursement, and PolicyConference Call ParticipantsRoss Osborn - Director and Lead Research AnalystDavid Turkaly - Research AnalystMichael Sarcone - AnalystAnthony Petrone - Managing Director, Senior Medical Devices, Diagnostics, and Therapeutics Equit ...